Blood Neoplasia
Elsevier · United States
Aims & Scope✦ Inferred from recent articles
Blood Neoplasia focuses on hematologic malignancies, including leukemias and lymphomas. Research covers therapeutic strategies such as targeted therapies (e.g., Menin inhibitors, B-cell lymphoma 2 inhibitors), immunotherapy (e.g., CAR T-cell therapy, PD-1 inhibitors), and novel drug combinations. The journal also investigates biomarkers like circulating tumor DNA (ctDNA) for disease monitoring and prognostic assessment, and explores the molecular pathogenesis of these cancers, including genomic alterations and resistance mechanisms.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref